Huisheng Biotech: Announcement on the 2023 Profit Distribution Plan
Huisheng Biotech: Legal Opinion of Guohao Lawyer (Shenzhen) Firm on the 2021 Restricted Stock Incentive Plan of Wuhan Huisheng Biotechnology Co., Ltd. to repurchase and cancel restricted stocks
Huisheng Biotech: Announcement on Repurchase and Cancellation of Restricted Shares under the 2021 Restricted Stock Incentive Plan
Huisheng Biotech: Announcement on the cancellation of the pledge of some of the controlling shareholder's shares
Huisheng Biotech: Announcement on related transactions involving the issuance of A-shares to specific targets in 2024
Huisheng Biotech: Feasibility Analysis Report on the Use of Funds Raised by Wuhan Huisheng Biotechnology Co., Ltd. to issue A-shares to specific targets in 2024
Huisheng Biotech: Shareholder dividend return plan for the next three years (2024-2026)
Huisheng Biotech: Announcement on the current issuance of A-shares to specific targets without providing financial support or compensation to investors directly or through stakeholders participating in the subscription
Huisheng Biotech: An indicative announcement on the disclosure of plans to issue A-shares to specific targets in 2024
Huisheng Biotech: An indicative announcement on proposed changes in the rights and interests of controlling shareholders and their concerted actors
Huisheng Biotech: Demonstration Analysis Report on Wuhan Huisheng Biotechnology Co., Ltd.'s 2024 A-share issuance plan to specific targets
Huisheng Biotech: Written review opinions of the board of supervisors on matters relating to the company's issuance of A-shares to specific targets in 2024
Huisheng Biotech: Wuhan Huisheng Biotechnology Co., Ltd.'s plan to issue A-shares to specific targets in 2024
Huisheng Biotech: CITIC Construction Investment Securities Co., Ltd.'s inspection opinions on related transactions involving the issuance of shares to specific targets by Wuhan Huisheng Biotechnology Co., Ltd. in 2024
Huisheng Biotech: Announcement on Issuing A Shares to Specific Targets with Diluted Spot Returns, Adoption of Corrective Measures and Related Commitments in 2024
Huisheng Biotech: Announcement on the controlling shareholder's partial share pledge
Huisheng Biotech: Announcement on the controlling shareholder's partial share pledge
Huisheng Biotech: Announcement on the controlling shareholder\'s partial share pledge
Huisheng Biotech: Announcement on the controlling shareholder\'s partial share pledge
Huisheng Biotech: Prompt Announcement on the Listing and Circulation of Issued Shares Before the Initial Public Offering
No Data